Squamous Intraepithelial Lesions

This is a finding from a lab test that looks at cells from your body. It means some of the cells on the surface of your body are looking a bit unusual or abnormal.

Condition

What people with Squamous Intraepithelial Lesions report

Every report comes from a Lived member, sent anonymously.

Have you had LEEP for Squamous Intraepithelial Lesions?

NameHow it went

About Squamous Intraepithelial Lesions

What It Is

A squamous intraepithelial lesion (SIL) is an area of abnormal cells in the thin, flat (squamous) layer of cells that lines the cervix, the lower end of the uterus. The term most often appears on a Pap test result. These changes are not cancer. They are graded by how abnormal the cells look, because the grade predicts how likely the area is to clear or to progress. A low-grade lesion (LSIL) shows mild changes, usually from a human papillomavirus (HPV) infection that often goes away on its own. A high-grade lesion (HSIL) shows moderate or severe changes that could become cancer over time if left untreated, which is why it is often called precancer. A related result, ASC-H (atypical squamous cells, cannot exclude HSIL), means some cells look worrying but the lab cannot tell whether high-grade change is present. These changes usually cause no symptoms, so they are almost always found through routine screening. The same low-grade and high-grade terms are also used for similar changes in the anus, vulva, vagina and penis.

Causes & Risk Factors

Nearly all squamous intraepithelial lesions are caused by HPV, a very common virus spread through intimate skin-to-skin contact, usually during sex. Most HPV infections are cleared by the immune system within a year or two. A lesion develops when a high-risk type of HPV persists and begins changing how cells grow. Types 16 and 18 cause most cervical cancers and carry the greatest risk. An HPV infection is not a sign of anything a person did wrong, and many people with HPV never develop a lesion. The infection is more likely to persist and progress in people with a weakened immune system, such as from HIV (human immunodeficiency virus) or medicines that suppress immunity, and in people who smoke. HPV vaccination, ideally before any exposure, greatly lowers the chance of infection with the highest-risk types.

How It's Diagnosed

A Pap test (cervical cytology) looks at loose cells brushed from the cervix and reports whether they appear normal, low-grade or high-grade. An HPV test on the same sample shows whether high-risk HPV is present. Under current US guidelines, the next step depends on your overall risk, which combines this result with your age, past results and health factors such as immune status, not on one result alone. An LSIL result with HPV is usually followed by repeat testing or colposcopy. HSIL and ASC-H results lead to colposcopy, an office exam in which the clinician uses a magnifying instrument and a vinegar solution to highlight abnormal areas and take small biopsies. The biopsy is graded as cervical intraepithelial neoplasia (CIN) 1, 2 or 3. CIN 1 corresponds to low-grade change, while CIN 2 and CIN 3 are high-grade changes, with CIN 3 the most advanced before cancer. Because a Pap test only samples cells, the biopsy grade usually guides treatment.

Treatment Options

Low-grade changes (LSIL or CIN 1) usually go away on their own, so the usual approach is follow-up testing rather than treatment. Treatment may be considered if a low-grade change persists for at least two years. High-grade changes are treated to remove or destroy the abnormal cells before they can become cancer. CIN 3 should be treated. CIN 2 is usually treated too, but because it sometimes clears on its own, especially in people under 25, close monitoring with colposcopy every six months is an option for some people. When a Pap and HPV result together point to a very high risk, some people aged 25 and older are offered treatment without waiting for a biopsy. The most common treatment is a loop electrosurgical excision procedure (LEEP), a short office procedure under local anesthetic in which a thin electrified wire loop removes the affected tissue so a lab can check it. A cone biopsy done with a scalpel in the hospital is an alternative. Ablation methods such as freezing (cryotherapy) or laser destroy the tissue instead of removing it and are used only when the whole affected area can be seen. Rarely, these treatments weaken the cervix and raise the risk of preterm birth or miscarriage in a later pregnancy, so pregnancy plans shape the choice and timing. During pregnancy, treatment is usually postponed until after delivery unless cancer is suspected. For people aged 27 to 45 who were never vaccinated, HPV vaccination around the time of treatment may help prevent recurrence. High-grade lesions in the anus are treated in a similar way. In a large trial of people with HIV, treating anal HSIL lowered the rate of progression to anal cancer by more than half compared with monitoring alone.

What to Expect

Most people with a squamous intraepithelial lesion never develop cancer, because low-grade changes usually resolve and high-grade changes are found and treated early. The main burden is the follow-up: more frequent visits and the worry of waiting for results. After a biopsy or LEEP, mild cramping and a watery, pinkish or brownish-black discharge are common. The cervix takes a few weeks to heal after LEEP, and during that time you should avoid sex, tampons and douching until your clinician says it is safe. Follow-up continues for years. After treatment for a high-grade change, an HPV-based test is done at six months, then yearly until three tests in a row are negative, and then every three years for at least 25 years, even beyond age 65. This long schedule reflects a lasting higher risk of the change coming back, not a sign that treatment failed. After a low-grade result, repeat testing usually returns you to the normal screening schedule once results stay reassuring.

When to Seek Help

Keep every follow-up appointment after an abnormal Pap or HPV test, and contact your clinician if you missed one or are unsure when your next test is due. Contact your care team promptly if you have bleeding after sex, bleeding between periods or after menopause, unusual vaginal discharge, or ongoing pelvic pain or pain during sex, since these are not typical of precancer and need to be checked. After a procedure, call if you have bleeding heavier than a normal period, bleeding with clots or severe abdominal pain.

Questions to Ask Your Doctor

  1. 1.Was my result low-grade or high-grade, and what does my overall risk mean for the next step?
  2. 2.Do you recommend monitoring or treatment for me, and why?
  3. 3.How could treatment affect a future pregnancy, and does that change which option or timing you would suggest?
  4. 4.What follow-up testing will I need, and for how many years?
  5. 5.Would HPV vaccination still help me now?

Last reviewed • Oct 2026

Educational content, not medical advice.